By moving beyond a simple binary classification, we sought to establish CD4+ T cells count as a key variable for optimizing initial empirical antimicrobial therapy and refining diagnostic pathways in severe pneumonia. The gene discussed is CD4; the disease is susceptibility to pneumonia measurement.